Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D for Painful Nocturnal Leg Cramps

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* One or more prescription for quinine at the Madison VA in the last 5 years, or else be a UWHC (U Wisconsin Health Clinics) patient whose UWHC medication list had quinine listed in the last five years~* At least 50 years of age, with women being past menopause. This is defined as the woman reporting no periods in the last 12 consecutive months or longer.~* Leg cramps listed in medical record,~* Ability \& willingness to give informed consent,~* Stable estimated Glomerular filtration rate (GFR)\>35 ml/min for the prior 6 mos,~* No change in diuretic therapy in last 3 months,~* Stable pattern of two or more cramps per week for past three months,~* Ability to complete daily diary entry,~* Post-consent: serum 25-OH of 20-45 ng/mL, albumin- corrected calcium \<10.3 mg/dL, and urine calcium/creatinine ratio \<0.25.~Exclusion Criteria:~* Not receiving primary care at Madison VAMC, or at UWHC~* Hyperparathyroidism (1°, 2°, or 3°),~* Osteomalacia ,~* Paget's disease,~* Metastatic cancer,~* Taking vitamin D 50,000 units capsules,~* Serum Ca++ \>10.3 mg/dL in subject chart,~* Sarcoidosis or tuberculosis, and~* Peripheral vascular disease or other condition confounding assessment of cramps.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- vitamin D 50,000 U/d x 10d, + vitamin D 50,000 U weekly 7 wks (Type: EXPERIMENTAL): Vitamin D arm
- placebo x 10d, + placebo weekly 7 wks (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).